We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
Cap. Flow
+$4.56B
Cap. Flow %
5.05%
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344

Sector Composition

Rank Sector Weight
1 Financials 11.61%
2 Technology 10.97%
3 Healthcare 10.51%
4 Consumer Discretionary 7.19%
5 Industrials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMNX
2676
DELISTED
Luminex Corp
LMNX
$1.15M ﹤0.01%
56,890
+22,778
+67% +$456K
MANT
2677
DELISTED
Mantech International Corp
MANT
$1.15M ﹤0.01%
30,325
+12,339
+69% +$423K
STBZ
2678
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$1.15M ﹤0.01%
56,372
-2,664
-5% -$54.8K
HMN icon
2679
Horace Mann Educators
HMN
$2.1B
$1.15M ﹤0.01%
33,920
+3,403
+11% +$111K
PWB icon
2680
Invesco Large Cap Growth ETF
PWB
$2.27B
$1.15M ﹤0.01%
+36,665
New +$1.14M
RRC icon
2681
PUT
Range Resources
RRC
$9.24B
$1.14M ﹤0.01%
+26,500
New +$1.09M
MDC
2682
DELISTED
M.D.C. Holdings, Inc.
MDC
$1.14M ﹤0.01%
65,117
+31,349
+93% +$542K
NSIT icon
2683
Insight Enterprises
NSIT
$3.86B
$1.14M ﹤0.01%
43,886
-1,054
-2% -$28.2K
AMJ
2684
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$1.14M ﹤0.01%
+35,838
New +$1.07M
CRAY
2685
DELISTED
Cray, Inc.
CRAY
$1.14M ﹤0.01%
38,087
-24,991
-40% -$875K
ZTS icon
2686
CALL
Zoetis
ZTS
$31.9B
$1.14M ﹤0.01%
+24,000
New +$1.13M
ONCE
2687
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.14M ﹤0.01%
22,259
-1,431
-6% -$61.1K
HQY icon
2688
HealthEquity
HQY
$8.44B
$1.14M ﹤0.01%
37,459
+26,419
+239% +$694K
VB icon
2689
Vanguard Morningstar Small-Cap ETF
VB
$79.6B
$1.14M ﹤0.01%
9,822
+4,653
+90% +$528K
PLKI
2690
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
$1.14M ﹤0.01%
20,780
-32
-0.2% -$1.74K
MGNI icon
2691
Magnite
MGNI
$2.78B
$1.14M ﹤0.01%
83,182
+50,496
+154% +$813K
ATW
2692
DELISTED
Atwood Oceanics
ATW
$1.14M ﹤0.01%
90,609
+41,573
+85% +$434K
NTUS
2693
DELISTED
Natus Medical Inc
NTUS
$1.13M ﹤0.01%
29,966
+11,022
+58% +$369K
VOE icon
2694
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.8B
$1.13M ﹤0.01%
12,678
+2,046
+19% +$180K
LTXB
2695
DELISTED
LegacyTexas Financial Group Inc
LTXB
$1.13M ﹤0.01%
41,860
-6,122
-13% -$149K
EVER
2696
DELISTED
Everbank Financial Corp
EVER
$1.13M ﹤0.01%
75,666
+27,752
+58% +$412K
BBVA icon
2697
Banco Bilbao Vizcaya Argentaria
BBVA
$152B
$1.12M ﹤0.01%
198,820
+137,206
+223% +$865K
W icon
2698
Wayfair
W
$11.9B
$1.12M ﹤0.01%
28,711
+11,823
+70% +$472K
CEA
2699
DELISTED
China Eastern Airlines
CEA
$1.12M ﹤0.01%
+44,228
New +$1.22M
ZEUS
2700
DELISTED
Olympic Steel
ZEUS
$1.12M ﹤0.01%
+40,984
New +$916K

Similar funds

Credit Suisse's Q2 2016 Portfolio in Review

As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.

  • Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
  • Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
  • Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
  • Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
  • Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
  • Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.